WP-1034, a novel Jak-Stat inhibitor, has proapoptotic and antileukemic activity in acute myeloid leukemia (AML) cell lines and AML patient samples.

被引：0
|
作者：
Faderl, S
Ferrajoli, A
Harris, D
Van, Q
Priebe, W
Estrov, Z
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Dev Therapeut, Houston, TX 77030 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2528
引用
收藏
页码：693A / 693A
页数：1
相关论文
共 32 条
  • [21] Novel and selective inhibitors of histone deacetylases (HDAC) 1 and 2 significantly enhance the activity of the DNA methyltransferase inhibitor azacitidine in acute myeloid leukemia (AML)
    Min, Chengyin
    Quayle, Steven N.
    Tamang, David
    Jones, Simon S.
    Yang, Min
    CANCER RESEARCH, 2015, 75
  • [22] A dual FLT-3 and MER tyrosine kinase small molecule inhibitor in acute myeloid leukemia cell lines and patient samples
    Sherick, Alisa Lee
    Menachof, Kelly
    Hill, Amanda
    Rinella, Sean
    DeRyckere, Deborah
    Liu, Jing
    Wang, Xiaodong
    Frye, Stephen
    Earp, H. Shelton
    Graham, Douglas
    CANCER RESEARCH, 2014, 74 (19)
  • [23] PKC412, an oral FLT3 inhibitor, has activity in mutant FLT3 acute myeloid leukemia (AML): A phase II clinical trial.
    Stone, RM
    Klimek, V
    DeAngelo, DJ
    Nimer, S
    Estey, E
    Galinsky, I
    Neuberg, D
    Yap, A
    Fox, EA
    Gilliland, DG
    Griffin, J
    BLOOD, 2002, 100 (11) : 86A - 86A
  • [24] APCK110, a novel and potent inhibitor of c-Kit, blocks phosphorylation of AKT and STAT3, induces apoptosis, and inhibits proliferation of acute myeloid leukemia (AML) cells.
    Faderl, Stefan
    Bornmann, William
    Maxwell, David
    Pal, Ashutosh
    Peng, Zheng-Hong
    Shavrin, Aleksandr
    Harris, David
    Van, Quin
    Liu, Zhiming
    Verstovsek, Srdan
    Manshouri, Taghi
    Ferrajoli, Alessandra
    Kantarjian, Hagop M.
    Estrov, Zeev
    BLOOD, 2006, 108 (11) : 49A - 50A
  • [25] Growth Inhibitory Function Of a Novel T-LAK Cell-Originated Protein Kinase Inhibitor On FLT3-ITD Positive Acute Myeloid Leukemia (AML) Cells
    Alachkar, Houda
    Park, Jae-Hyun
    Nakakido, Makoto
    Wood, Alex
    Raca, Gordana
    Matsuo, Yo
    Stock, Wendy
    Nakamura, Yusuke
    BLOOD, 2013, 122 (21)
  • [26] Comparative gene profiling of acute myeloid leukemia (AML) and malignant melanoma (MEL) cell lines exposed to the MEK inhibitor PD0325901 reveals common effectors of the MEK/ERK kinase module
    Milella, Michele
    Chiaretti, Sabina
    Ricciardi, Maria R.
    Tavolaro, Simona
    Ciuffreda, Ludovica
    Benassi, Barbara
    Bellacosa, Alfonso
    Peluso, Gianfra. Nco
    Bergamo, Paola
    McCubrey, Janies A.
    Cognetti, Francesco
    Zupi, Gabriella
    Foa, Robert
    Tafuri, Agostino
    BLOOD, 2007, 110 (11) : 1017A - 1017A
  • [27] C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation
    Al Shahrani, Mesfer
    Gahtani, Reem M.
    Makkawi, Mohammed
    MEDICAL ONCOLOGY, 2024, 41 (03)
  • [28] C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation
    Mesfer Al Shahrani
    Reem M. Gahtani
    Mohammed Makkawi
    Medical Oncology, 41
  • [29] Translational in vivo and in vitro studies in patients (pts) with acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and myeloproliferative disease (MPD) treated with MK-0457 (MK), a novel aurora kinase, Flt3, JAK2, and Bcr-Abl inhibitor.
    Tibes, Raoul
    Giles, Francis
    McQueen, Teresa
    Bergstrom, Donald A.
    Freedman, Steven J.
    Andreeff, Michael
    BLOOD, 2006, 108 (11) : 397A - 398A
  • [30] Combining IMGN779, a Novel Anti-CD33 Antibody-Drug Conjugate (ADC), with the PARP Inhibitor, Olaparib, Results in Enhanced Anti-Tumor Activity in Preclinical Acute Myeloid Leukemia (AML) Models
    Portwood, Scott
    Puchalski, Robert A.
    Walker, Russell M.
    Wang, Eunice S.
    BLOOD, 2016, 128 (22)
1234